{"schema_version":"secwatch.filing_event.v1","accession":"0001014739-23-000040","form_type":"8-K","ticker":"OPCH","cik":"0001014739","company_name":"Option Care Health, Inc.","filed_at":"2023-10-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.867232+00:00","generated_at":"2026-06-09T09:37:06.341357+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Option Care Health Q3 net income up 45% to $56.3M; guides FY23 revenue $4.23B-$4.28B","bullets":["Net revenue $1,093.0M (+7.1% YoY); gross profit margin expanded to 23.3% from 21.4%.","Net income $56.3M ($0.31 basic EPS) vs $38.8M ($0.21) in Q3 2022, +45%.","Adjusted EBITDA $109.8M, up 28.2% YoY; cash flow from operations $61.0M.","FY2023 guidance: net revenue $4.23B-$4.28B, Adj. EBITDA $420M-$425M, CFO at least $350M."],"urls":{"canonical":"https://secwatch.observer/filing/0001014739-23-000040","json":"https://secwatch.observer/filing/0001014739-23-000040.json","markdown":"https://secwatch.observer/filing/0001014739-23-000040.md","text":"https://secwatch.observer/filing/0001014739-23-000040.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1014739/000101473923000040/0001014739-23-000040-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1014739/000101473923000040/bios-20231025.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T09:37:06.341357+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f386bc796c535d927e8663461034983f270c505d","claim":"Option Care Health, Inc. reported third quarter ended September 30, 2023 results: revenue $1,093.0 million, net income $56.3 million, EPS $0.31 basic earnings per share.","evidence_excerpt":"site infusion services, announced today financial results for the third quarter ended September 30, 2023. Third Quarter 2023 Financial Results and Highlights • Net revenue of $1,093.0 million, up 7.1% compared to $1,020.9 million in the third quarter of 2022 • Gross profit of $254.3 million, or 23.3% of net revenue, up 16.6% compared to $218.0 million, or 21.4% of net","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1014739/000101473923000040/0001014739-23-000040-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter ended September 30, 2023"},{"label":"Revenue","value":"$1,093.0 million"},{"label":"Net income","value":"$56.3 million"},{"label":"EPS","value":"$0.31 basic earnings per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}